Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-059348
Filing Date
2025-04-28
Accepted
2025-04-28 16:30:15
Documents
17
Period of Report
2025-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A olma-20250428.htm   iXBRL DEF 14A 1464291
2 GRAPHIC img209107431_0.jpg GRAPHIC 721771
3 GRAPHIC img209107431_1.jpg GRAPHIC 795070
4 GRAPHIC img209107431_2.jpg GRAPHIC 1729992
5 GRAPHIC img209107431_3.jpg GRAPHIC 1330559
  Complete submission text file 0000950170-25-059348.txt   13494621

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT olma-20250428.xsd EX-101.SCH 8266
19 EXTRACTED XBRL INSTANCE DOCUMENT olma-20250428_htm.xml XML 624633
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39712 | Film No.: 25880837
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)